Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Viral sepsis - pathophysiology and disease manifestation.

Infection·2025
Same author

COVID-19: A case for plasma derived natural anticoagulants?

Biologicals : journal of the International Association of Biological Standardization·2024
Same author

Too Early to Abandon Convalescent Plasma for Supportive Treatment of COVID-19.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2024
Same author

Heterozygosity in factor XIII genes and the manifestation of mild inherited factor XIII deficiency.

Journal of thrombosis and haemostasis : JTH·2023
Same author

"Thromboinflammation in COVID-19: can α2-macroglobulin help to control the fire?": Comment from Seitz et al.

Journal of thrombosis and haemostasis : JTH·2023
Same author

Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine?

Infection·2021

Related Experiment Video

Updated: May 12, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

Factor XIIIa generation assay: a tool for studying factor XIII function in plasma.

Johannes Dodt1, Peter Volkers, Rainer Seitz

  • 1Paul Ehrlich Institut, 63225 Langen, Germany. johannes.dodt@pei.de

Analytical Biochemistry
|April 25, 2013
PubMed
Summary

A novel assay monitors factor XIIIa (FXIIIa) generation, revealing dose-dependent responses and the supportive role of FXIII-B in cellular FXIII activation. This method offers deeper insights into FXIII function than standard assays.

Keywords:
Factor XIIIFactor XIIIaFactor XIIIa generation assayPlasma transglutaminase

More Related Videos

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
08:01

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

Extracellular Vesicle Tissue Factor Activity Assay
03:53

Extracellular Vesicle Tissue Factor Activity Assay

Published on: December 29, 2023

Related Experiment Videos

Last Updated: May 12, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
08:01

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

Extracellular Vesicle Tissue Factor Activity Assay
03:53

Extracellular Vesicle Tissue Factor Activity Assay

Published on: December 29, 2023

Area of Science:

  • Biochemistry
  • Hematology
  • Coagulation Science

Background:

  • Factor XIII (FXIII) is a crucial plasma transglutaminase involved in clot stabilization.
  • Standard assays often quantify FXIII after complete activation, potentially missing dynamic activation processes.
  • Understanding FXIII activation kinetics is vital for diagnosing and managing bleeding disorders.

Purpose of the Study:

  • To develop and validate a novel fluorogenic assay for continuous monitoring of FXIIIa generation.
  • To characterize the activation kinetics of different FXIII-A preparations (recombinant and cellular).
  • To investigate the role of FXIII-B in the activation of cellular FXIII (cFXIII).

Main Methods:

  • Triggering the extrinsic coagulation pathway to initiate FXIII activation.
  • Utilizing a fluorogenic FXIIIa substrate for continuous monitoring of FXIIIa activity.
  • Calculating key kinetic parameters: Area Under the Curve (AUC), Time To Peak (TTP), and Concentration at Peak (CP).
  • Assessing dose-response relationships of FXIII dilutions and different FXIII-A preparations.

Main Results:

  • AUC and CP demonstrated linear dose-response relationships in normal plasma dilutions.
  • TTP increased with FXIII concentration in normal plasma.
  • Recombinant FXIII (rFXIII) and cellular FXIII (cFXIII) showed linear AUC and CP responses.
  • cFXIII exhibited a concentration-dependent increase in TTP, unlike rFXIII.
  • FXIII-B addition enhanced AUC and accelerated TTP for cFXIII, suggesting a supportive role in activation.
  • A commercial FXIII assay did not differentiate cFXIII preparations with or without FXIII-B.

Conclusions:

  • The FXIIIa generation assay provides dynamic insights into FXIII activation kinetics.
  • FXIII-B plays a supportive role in the activation of cFXIII by thrombin.
  • This assay offers advantages over conventional methods by revealing functional differences and activation dynamics.